UBS Asset Management Americas Inc. cut its stake in shares of Exponent Inc. (NASDAQ:EXPO) by 9.0% during the second quarter, Holdings Channel reports. The institutional investor owned 51,757 shares of the company’s stock after selling 5,137 shares during the period. UBS Asset Management Americas Inc. owned about 0.19% of Exponent worth $3,024,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in the stock. Advisory Services Network LLC increased its position in Exponent by 2.2% in the second quarter. Advisory Services Network LLC now owns 2,781 shares of the company’s stock valued at $162,000 after buying an additional 59 shares in the last quarter. BB&T Corp bought a new position in Exponent during the second quarter valued at approximately $273,000. Jacobs Levy Equity Management Inc. increased its position in Exponent by 5.8% in the first quarter. Jacobs Levy Equity Management Inc. now owns 5,630 shares of the company’s stock valued at $287,000 after buying an additional 310 shares in the last quarter. BlackRock Inc. increased its position in Exponent by 18.4% in the first quarter. BlackRock Inc. now owns 6,498 shares of the company’s stock valued at $332,000 after buying an additional 1,008 shares in the last quarter. Finally, Aperio Group LLC increased its position in Exponent by 15.1% in the first quarter. Aperio Group LLC now owns 7,084 shares of the company’s stock valued at $361,000 after buying an additional 932 shares in the last quarter. 91.46% of the stock is currently owned by institutional investors and hedge funds.
Exponent Inc. (NASDAQ:EXPO) traded up 0.26% during mid-day trading on Wednesday, hitting $50.37. 15,250 shares of the stock were exchanged. Exponent Inc. has a 12-month low of $44.82 and a 12-month high of $59.71. The company has a 50 day moving average of $50.23 and a 200 day moving average of $51.95. The firm has a market cap of $1.31 billion, a P/E ratio of 28.78 and a beta of 0.85.
Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Tuesday, July 19th. The company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.43 by $0.05. The firm had revenue of $77.30 million for the quarter, compared to analyst estimates of $80.46 million. Exponent had a net margin of 15.13% and a return on equity of 16.02%. On average, equities analysts anticipate that Exponent Inc. will post $1.59 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Friday, September 2nd were issued a $0.18 dividend. The ex-dividend date was Wednesday, August 31st. This represents a $0.72 annualized dividend and a yield of 1.43%. Exponent’s dividend payout ratio (DPR) is currently 41.62%.
Several research analysts recently commented on EXPO shares. Cantor Fitzgerald started coverage on shares of Exponent in a research note on Friday, August 26th. They issued a “buy” rating and a $57.00 price target on the stock. Zacks Investment Research raised shares of Exponent from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 20th. Finally, Avondale Partners initiated coverage on shares of Exponent in a report on Thursday, July 7th. They set a “market perform” rating and a $60.00 target price on the stock.
In related news, insider Paul Boehm sold 5,000 shares of the business’s stock in a transaction dated Monday, July 25th. The shares were sold at an average price of $51.42, for a total value of $257,100.00. Following the sale, the insider now directly owns 29,045 shares in the company, valued at approximately $1,493,493.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Paul R. Johnston sold 5,578 shares of the business’s stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $58.15, for a total transaction of $324,360.70. Following the completion of the sale, the chief executive officer now owns 64,458 shares in the company, valued at $3,748,232.70. The disclosure for this sale can be found here. 3.50% of the stock is currently owned by corporate insiders.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.